Baxter International (STU:BTL) Tax Provision : €-43 Mil (TTM As of Sep. 2024)

View and export this data going back to . Start your Free Trial

What is Baxter International Tax Provision?

Baxter International's tax provision for the three months ended in Sep. 2024 was €-7 Mil. Its tax provision for the trailing twelve months (TTM) ended in Sep. 2024 was €-43 Mil.

Baxter International Tax Provision Historical Data

The historical data trend for Baxter International's Tax Provision can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Baxter International Tax Provision Chart

Baxter International Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Tax Provision

Get a 7-Day Free Trial

36.90

-149.60

-73.46

-3.78

31.18

Baxter International Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
Tax Provision	Get a 7-Day Free Trial															-25.30	85.28	-70.84	-50.17	-7.21

Baxter International Tax Provision Calculation

Tax to be paid.

Tax Provision for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €-43 Mil.

Baxter International Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Baxter International Inc (STU:BTL) » Definitions » Tax Provision

Comparable Companies

Traded in Other Exchanges

BAX:USA BAX:Mexico 1BAX:Italy 0QK8:UK BTL:Germany BTL:Germany BAX:Austria

Address

One Baxter Parkway, Deerfield, IL, USA, 60015

Website

https://www.baxter.com

Baxter offers a variety of medical supplies and equipment to providers. From its legacy operations, Baxter sells injectable therapies for use in care settings, including IV pumps, administrative sets, and solutions; nutritional products; and surgical sealants and hemostatic agents. Baxter expanded its portfolio of hospital-focused offerings by acquiring Hillrom in late 2021, which added basic equipment like hospital beds, operating room equipment, and patient monitoring tools to the portfolio. Baxter has signed an agreement to sell its kidney care tools by early 2025.

Baxter International Headlines

No Headlines